Pfizer slashes R&D

被引:0
|
作者
Daniel Cressey
机构
来源
Nature | 2011年 / 470卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Drug-maker plans to cut jobs and spending as industry shies away from drug discovery.
引用
收藏
页码:154 / 154
相关论文
共 50 条
  • [41] The effect of R&D subsidies on private R&D
    Gorg, Holger
    Strobl, Eric
    [J]. ECONOMICA, 2007, 74 (294) : 215 - 234
  • [42] R&D HETEROGENEITY AND THE IMPACT OF R&D SUBSIDIES
    Galaasen, Sigurd Molster
    Irarrazabal, Alfonso
    [J]. ECONOMIC JOURNAL, 2021, 131 (640): : 3338 - 3364
  • [43] R&D management conference on 'quality and R&D'
    Fisscher, O
    KerssensvanDrongelen, I
    deWeerdNederhof, P
    [J]. R & D MANAGEMENT, 1996, 26 (04) : 381 - 389
  • [44] R&D cooperation and the joint exploitation of R&D
    Brod, A
    Shivakumar, R
    [J]. CANADIAN JOURNAL OF ECONOMICS-REVUE CANADIENNE D ECONOMIQUE, 1997, 30 (03): : 673 - 684
  • [45] R&D Spillovers for Public R&D Productivity
    Kwon, Hye Yeon
    Kwon, Illoong
    [J]. GLOBAL ECONOMIC REVIEW, 2019, 48 (03) : 334 - 349
  • [46] Systemic aspects of R&D policy subsidies for R&D collaborations and their effects on private R&D
    Engel, Dirk
    Rothgang, Michael
    Eckl, Verena
    [J]. INDUSTRY AND INNOVATION, 2016, 23 (02) : 206 - 222
  • [49] Stock options, R&D, and the R&D tax credit
    Brown, Jennifer L.
    Krull, Linda K.
    [J]. ACCOUNTING REVIEW, 2008, 83 (03): : 705 - 734
  • [50] Wage Inequality, R&D Labor and R&D Productivity
    Okada, Toshihiro
    [J]. ECONOMICS BULLETIN, 2012, 32 (04): : 3036 - 3052